Related Experiment Video
Updated: Oct 19, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry
Mateusz Sokolski1,2, Sander Trenson2,3, Justyna M Sokolska1,2
1Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
Insights
Hospitalized patients with COVID-19 and heart failure (HF) faced higher in-hospital mortality. Acute HF events during hospitalization further increased death risk, underscoring HF
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Heart failure (HF) is a significant comorbidity impacting outcomes in hospitalized patients.
- Coronavirus disease 2019 (COVID-19) has been associated with cardiovascular complications.
- The interplay between HF and COVID-19 requires further investigation to understand mortality risks.
Purpose of the Study:
- To compare the outcomes of hospitalized COVID-19 patients with HF against those with other cardiovascular diseases or risk factors.
- To determine the incidence of HF events during COVID-19 hospitalization.
- To assess the consequences of HF events on mortality in COVID-19 patients.
Main Methods:
- Retrospective analysis of the Postgraduate Course in Heart Failure registry (PCHF-COVICAV) data.
- Inclusion of patients hospitalized with COVID-19 and cardiovascular disease/risk factors from 28 centers in 15 countries.
- Primary endpoint: in-hospital mortality; secondary analysis of acute HF events and their impact.
Main Results:
- Of 1282 COVID-19 patients with cardiovascular disease/risk factors, 256 (20%) had HF. Overall in-hospital mortality was 25%.
- Patients with HF had significantly higher in-hospital mortality (36%) compared to non-HF patients (23%, OR 1.93, P < 0.001).
- 15% of patients experienced acute HF events during hospitalization (de novo HF in 40%), associated with substantially higher mortality (48% vs. 23%, OR 3.10, P < 0.001).
Conclusions:
- Hospitalized COVID-19 patients with a history of HF face a significantly increased risk of in-hospital death.
- Acute heart failure events, including new-onset HF, are common during COVID-19 hospitalization.
- These HF events are associated with a further, substantial rise in in-hospital mortality, highlighting the critical impact of HF management in this population.
Aims:
We assessed the outcome of hospitalized coronavirus disease 2019 (COVID-19) patients with heart failure (HF) compared with patients with other cardiovascular disease and/or risk factors (arterial hypertension, diabetes, or dyslipidaemia). We further wanted to determine the incidence of HF events and its consequences in these patient populations.
Methods And Results:
International retrospective Postgraduate Course in Heart Failure registry for patients hospitalized with COVID-19 and CArdioVascular disease and/or risk factors (arterial hypertension, diabetes, or dyslipidaemia) was performed in 28 centres from 15 countries (PCHF-COVICAV). The primary endpoint was in-hospital mortality. Of 1974 patients hospitalized with COVID-19, 1282 had cardiovascular disease and/or risk factors (median age: 72 [interquartile range: 62-81] years, 58% male), with HF being present in 256 [20%] patients. Overall in-hospital mortality was 25% (n = 323/1282 deaths). In-hospital mortality was higher in patients with a history of HF (36%, n = 92) compared with non-HF patients (23%, n = 231, odds ratio [OR] 1.93 [95% confidence interval: 1.44-2.59], P < 0.001). After adjusting, HF remained associated with in-hospital mortality (OR 1.45 [95% confidence interval: 1.01-2.06], P = 0.041). Importantly, 186 of 1282 [15%] patients had an acute HF event during hospitalization (76 [40%] with de novo HF), which was associated with higher in-hospital mortality (89 [48%] vs. 220 [23%]) than in patients without HF event (OR 3.10 [2.24-4.29], P < 0.001).
Conclusions:
Hospitalized COVID-19 patients with HF are at increased risk for in-hospital death. In-hospital worsening of HF or acute HF de novo are common and associated with a further increase in in-hospital mortality.
More Related Videos
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management

